Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Boyle James M 2. Issuer Name and Ticker or Trading Symbol Medline Inc. [MDLN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O MEDLINE INC., 3 LAKES DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 12/16/2025 (Street) NORTHFIELD, IL 60093 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class B Common Stock 12/16/2025 A(1) 24,313(2) A (1) 24,313 D Class B Common Stock 12/16/2025 A(1) 514,876(2) A (1) 514,876 I See Footnote(3) Class A Common Stock 03/05/2026 A(4) 31,739 A $ 0 31,739 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Units of Medline Holdings, LP	(5)	12/16/2025		A(1)		24,313		(5)	(5)	Class A Common Stock	24,313	(1)	24,313	I	See Footnote(5)
Common Units of Medline Holdings, LP	(5)	12/16/2025		A(1)		514,876		(5)	(5)	Class A Common Stock	514,876	(1)	514,876	I	See Footnote(3)(5)
Incentive Units of Medline Holdings, LP	$15.42(6)(7)	12/16/2025		A(1)		1,201,584		(6)(7)(8)	(6)(7)(8)	Class A Common Stock	1,201,584	(1)	1,201,584	I	See Footnote(6)(7)
Incentive Units of Medline Holdings, LP	$15.23(6)(7)	12/16/2025		A(1)		340,407		(6)(7)(9)	(6)(7)(9)	Class A Common Stock	340,407	(1)	340,407	I	See Footnote(6)(7)
Incentive Units of Medline Holdings, LP	$16.49(6)(7)	12/16/2025		A(1)		1,146,379		(6)(7)(10)	(6)(7)(10)	Class A Common Stock	1,146,379	(1)	1,146,379	I	See Footnote(6)(7)
Incentive Units of Medline Holdings, LP	$19.01(6)(7)	12/16/2025		A(1)		252,481		(6)(7)(11)	(6)(7)(11)	Class A Common Stock	252,481	(1)	252,481	I	See Footnote(6)(7)
Incentive Units of Medline Holdings, LP	$27.68(6)(7)	12/16/2025		A(1)		183,699		(6)(7)(12)	(6)(7)(12)	Class A Common Stock	183,699	(1)	183,699	I	See Footnote(6)(7)
Incentive Units of Medline Holdings, LP	$15.42(6)(7)	12/16/2025		A(1)		1,057,309		(6)(7)(13)	(6)(7)(13)	Class A Common Stock	1,057,309	(1)	1,057,309	I	See Footnote(3)(6)(7)

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Boyle James M C/O MEDLINE INC. 3 LAKES DRIVE NORTHFIELD, IL 60093	X		Chief Executive Officer

Signatures

/s/ Nicole Fritz, Attorney-in-Fact		03/06/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
(2)	Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each common unit of Medline Holdings, LP ("Common Units") held. Upon an exchange of Common Units for shares of the Issuer's Class A common stock ("Class A Common Stock"), an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.
(3)	These securities are held by a family trust of which the Reporting Person's spouse is the trustee.
(4)	Represents a grant of restricted stock units ("RSUs"), of which 25% vest on June 15, 2026 and the remaining 75% vest in three equal annual installments beginning on March 1, 2027.
(5)	Pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"), holders have the right to exchange their Common Units for shares of the Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC.
(6)	Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
(7)	(Continued from Footnote 6 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.
(8)	62% of these Incentive Units have vested, and the remaining 38% vest on October 21, 2026.
(9)	40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on April 1, 2026.
(10)	40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on October 1, 2026.
(11)	20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on March 29, 2026.
(12)	These Incentive Units vest in five equal annual installments beginning on March 28, 2026.
(13)	These Incentive Units are fully vested.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.